Absolute risk and therapeutic decision in hypertensive patients;Risque absolu et decision d'intervention chez le malade hypertendu

Revue du Praticien

Volumn 49, Issue 5, 2000, Pages 503-509

  Cambou, Jean Pierre ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; PRAVASTATIN; SIMVASTATIN;

AGE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DIABETES MELLITUS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MEDICAL DECISION MAKING; REVIEW; RISK ASSESSMENT; SMOKING; ADULT; AGED; ARTICLE; DECISION MAKING; FEMALE; HEART DISEASE; MALE; MIDDLE AGED; RISK FACTOR;

ADULT; AGE FACTORS; AGED; DECISION MAKING; DIABETES COMPLICATIONS; FEMALE; HEART DISEASES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; SMOKING;

EID: 0033088157     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med 1993 ; 153 : 598-615.
2. Kannel WB. Blood pressure as a cardiovascular risk factor. JAMA 1996 ; 275 : 1571-76.
3. 3.The Sixth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997 ; 157 : 2346-73.
4. Chalmers J, Zanchetti A. The 1996 report of a World Health Organization expert committee on hypertension control. J Hypertens 1996 ; 14 : 929-33.
5. Ménard J, Chatellier G, Tache A. Le calcul du risque cardiovasculaire. La Lettre du Cardiologue 1996 ; 266 : 3-7.
6. Rudnichi A, Safar M, Asmar R, Benetos A. Prevalence of cardiovascular risk factor in a French population. J Hypertens 1998 ; 16 : 85-90.
7. Assmann G, Schulte H. Results and conclusions of the Prospective Cardiovascular Münster (PROCAM) Study. In : Assmann G (ed.) Lipid metabolism disorders and coronary heart disease, 2nd ed. Munchen : MMV Medizin Verlag, 1993 : 19-68.
8. Ducimetière P, Richard JL, Cambien F, Rakotovao R, Claude JR. Coronary heart disease in middle-aged Frenchmen. Comparisons between Paris prospective study, seven countries study, and pooling project. Lancet 1980 ; 1 : 1346-50.
9. Gordon T, Kannel W. Multiple risk functions for predicting coronary heart disease: the concept, accuracy, and application. Am Heart J 1982 ; 103 : 1031-9.
10. Laurier D, Chau N, Cazelles B, Segond P and the PCV-METRA Group. Estimation of CHD risk in a French working population using a modified Framingham model. J Clin Epidemiol 1994 ; 47 : 1353-64.
11. Prevention of coronary heart disease in clinical practice. Summary of recommendations of the second joint task force of European and other society in Coronary Prevention (Prepared by David Wood, Guy de Backer, Ole Faergeman, Ian Graham, Giusseppe Mancia and Kareli Pyörälä, together with the members of the Task Force). (Document édité par la Société européenne de cardiologie).
12. Guidelines for the management of midly raised blood pressure in New Zealand Wellington : Core Service Committee, Ministry of Health, 1995.
13. Anderson KM, Wilson PWF, Odell PM, Kannel WB. An updated coronary risk profile. A statement for Health Professionals. Circulation 1991 ; 83 : 356-62.
14. MacMahon S, Peto R, Cutler J et al. Blood pressure, stroke and coronary heart disease. Part I, Prolonged differences in blood pressure : Prospective observational studies corrected for the regression dilution basis. Lancet 1990 ; 335 : 765-74.
15. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997 ; 20 : 1183-97.
16. Simpson FO. Guidelines for antihypertensive therapy : problems with a strategy based on absolute cardiovascular risk. J Hypertens 1996 ; 14 : 683-9.
17. Haq IU, Jackson PR, Yeo WW, Ramsay LE. Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary disease. Lancet 1995 ; 346 : 1467-71.
18. Krakoff LR. American Society of Hypertension Workshop on Absolute Risk. Am J Hypertens 1996 ; 9 : 397-9.
19. Staessen J, Bulpitt C, Clement D et al. Relation between mortality and treated blood pressure in elderly patients with hypertension : Report of the European Working Party on High Blood Pressure in the Elderly. BMJ 1989 ; 298 : 1552-6.
20. Jackson R, Barham P, Bills J et al. Management of raised blood pressure in New Zealand :A discussion document. BMJ 1993 ; 307 : 107-10.
21. Swales JD. Economics and the treatment of hypertension. J Hypertens 1995 ; 13 : 1357-61.
22. Alderman MH. Blood pressure management : individualized treatment based on absolute risk and the potential for benefit. Ann Intern Med 1993 ; 119 : 329-35.